The General Overview and Molecular Pathogenesis of Pancreatic Cancer

1. Bilimoria KY, Bentrem DJ, Ko CY, Ritchey J, Stewart AK, Winchester DP, Talamonti MS. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database // Cancer, 2007; 110:738 - 744Search in Google Scholar

2. Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors // J Am Coll Surg, 2004; 198:722 -731Search in Google Scholar

3. Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio- Donahue C, Jimeno A, Gabrielson KL, Matsui W, Maitra A. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers // Cancer Res, 2007; 67:2187 - 2196Search in Google Scholar

4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 // Eur J Cancer, 2013; 49:1374 - 1403Search in Google Scholar

5. Hamidov Z, Altendorf-Hofmann A, Chen Y, Settmacher U, Petersen I, Knösel T. Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma // J Clin Pathol, 2011; 64:990 - 994Search in Google Scholar

6. Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M. Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas // Br J Cancer, 2011; 104:1296 -1302Search in Google Scholar

7. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio- Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses // Science, 2008; 321:1801 - 1806Search in Google Scholar

8. Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK. Early diagnosis of pancreatic cancer: challenges and new developments // Biomark Med, 2012; 6:597 -612Search in Google Scholar

9. Kppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Tumours of the exocrine pancreas // Hamilton SR, Aaltonen LA. World Health Organization classification of tumours. Pathology and genetics of tumours of the digestive system. Lyon: IARC; 2000; 219 - 230Search in Google Scholar

10. Krantz SB, Shields MA, Dangi-Garimella S, Munshi HG, Bentrem DJ. Contribution of epithelial-tomesenchymal transition and cancer stem cells to pancreatic cancer progression // J Surg Res, 2012; 173:105 - 112Search in Google Scholar

11. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients // Ann Surg, 2003; 237:74 - 85Search in Google Scholar

12. Lynch HT, Brand RE, Deters CA, Shaw TG, Lynch JF. Hereditary pancreatic cancer // Pancreatology, 2001; 1:466 - 471Search in Google Scholar

13. Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis // J Surg Oncol, 2013; 107:8 - 14Search in Google Scholar

14. McCleary-Wheeler AL, Lomberk GA, Weiss FU, Schneider G, Fabbri M, Poshusta TL, Dusetti NJ, Baumgart S, Iovanna JL, Ellenrieder V, Urrutia R, Fernandez-Zapico ME. Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis // Cancer Lett, 2013; 328:212 - 221Search in Google Scholar

15. Momi N, Kaur S, Krishn SR, Batra SK. Discovering the route from inflammation to pancreatic cancer // Minerva Gastroenterol Dietol, 2012; 58:283 - 297Search in Google Scholar

16. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer // Cancer, 1995; 76:1671 - 1677Search in Google Scholar

17. Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S. Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer // Ann Surg, 2013; 258:336 - 346Search in Google Scholar

18. Pannala R, Basu A, Petersen GM, Chari ST. Newonset diabetes: a potential clue to the early diagnosis of pancreatic cancer // Lancet Oncol, 2009; 10:88 -95Search in Google Scholar

19. Pavai S, Yap SF. The clinical significance of elevated levels of serum CA 19-9 // Med J Malaysia, 2003; 58:667 - 672Search in Google Scholar

20. Poi MJ, Knobloch TJ, Yuan C, Tsai MD, Weghorst CM, Li J. Evidence that P12, a specific variant of P16(INK4A), plays a suppressive role in human pancreatic carcinogenesis // Biochem Biophys Res Commun, 2013, 436:217 - 22210.1016/j.bbrc.2013.05.078375242423727582Search in Google Scholar

21. Rohan VS, Hsu JT, Liu KH, Yeh CN, Yeh TS, Jan YY, Hwang TL. Long-term results and prognostic factors in resected pancreatic body and tail adenocarcinomas // J Gastrointest Cancer, 2013; 44:89 - 93Search in Google Scholar

22. Rosty C, Geradts J, Sato N, Wilentz RE, Roberts H, Sohn T, Cameron JL, Yeo CJ, Hruban RH, Goggins M. p16 inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis // Am J Surg Pathol, 2003; 27:1495 -1501Search in Google Scholar

23. Sato N, Fukushima N, Hruban RH, Goggins M. CpG island methylation profile of pancreatic intraepithelial neoplasia // Mod Pathol, 2008; 21:238 - 244Search in Google Scholar

24. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. Abrogation of the Rb/p16 tumorsuppressive pathway in virtually all pancreatic carcinomas // Cancer Res, 1997; 57:3126 - 3130Search in Google Scholar

25. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 // CA Cancer J Clin, 2012; 62:10 - 29Search in Google Scholar

26. Simtniece Z, Strumfa I, Abolins A, Vanags A, Gardovskis J. Prognostic factors after curative resection of pancreatic ductal adenocarcinoma: a retrospective study // Journal of Cancer Therapeutics & Research, 2012; 1:http://www. hoajonline.com/jctr/2049-7962/1/27#10.7243/2049-7962-1-27Search in Google Scholar

27. Takaori K, Hruban RH, Maitra A, Tanigawa N. Current topics on precursors to pancreatic cancer // Adv Med Sci, 2006; 51:23 - 30Search in Google Scholar

28. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernándezdel Castillo C, Yajnik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis // Nature, 2003; 425:851 - 856Search in Google Scholar

29. Tummala P, Junaidi O, Agarwal B. Imaging of pancreatic cancer: an overview // J Gastrointest Oncol, 2011; 2:168 - 174Search in Google Scholar

30. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer // Gastroenterology, 2013; 144:1252 - 1261 Search in Google Scholar